BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15916681)

  • 1. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
    Janssen-Heijnen ML; van Spronsen DJ; Lemmens VE; Houterman S; Verheij KD; Coebergh JW
    Br J Haematol; 2005 Jun; 129(5):597-606. PubMed ID: 15916681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.
    van Spronsen DJ; Janssen-Heijnen ML; Lemmens VE; Peters WG; Coebergh JW
    Eur J Cancer; 2005 May; 41(7):1051-7. PubMed ID: 15862755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.
    Moser EC; Kluin-Nelemans HC; Carde P; Meerwaldt JH; Tirelli U; Aleman BM; Baars J; Thomas J; van Glabbeke M; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1168-77. PubMed ID: 16887289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital.
    Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM
    Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
    Maksymiuk AW; Haines C; Tan LK; Skinnider LF
    Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost determinants in aggressive non-Hodgkin's lymphoma.
    van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
    Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
    Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of international prognostic index in non Hodgkin's lymphoma in Pakistan.
    Aziz Z; Sana S; Saeed S; Akram M
    J Ayub Med Coll Abbottabad; 2004; 16(2):15-20. PubMed ID: 15455610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands.
    Janssen-Heijnen ML; Lemmens VE; van den Borne BE; Biesma B; Oei SB; Coebergh JW
    Crit Rev Oncol Hematol; 2007 May; 62(2):172-8. PubMed ID: 17197191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
    Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
    Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V
    Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
    Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study.
    Oehler-Jänne C; Taverna C; Stanek N; Negretti L; Lütolf UM; Ciernik IF
    Hematol Oncol; 2008 Jun; 26(2):82-90. PubMed ID: 18085574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.